TG THERAPEUTICS, INC. (TGTX) Executive Compensation
TG THERAPEUTICS, INC. (TGTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TGTX
CIK: 1001316
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerLewis Bird
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-09-14 | 2026-09-10 | FORM 4 | 0001437749-26-030343 | View SEC Doc Filr Page |
| 144 | 2026-09-10 | — | 144 Filing | 0001959173-26-006866 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-06 | FORM 4 | 0001437749-26-026608 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | FORM 10-Q | 0001437749-26-025955 | View SEC Doc Filr Page |
| 8-K | 2026-08-03 | 2026-08-03 | FORM 8-K | 0001437749-26-025304 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020679 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020677 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020676 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020675 | View SEC Doc Filr Page |
| 4 | 2026-06-15 | 2026-06-11 | FORM 4 | 0001437749-26-020673 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-11 | FORM 8-K | 0001437749-26-020491 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | FORM 8-K | 0001437749-26-019262 | View SEC Doc Filr Page |
| 8-K | 2026-05-27 | 2026-05-27 | FORM 8-K | 0001437749-26-018586 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | FORM 10-Q | 0001437749-26-015246 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | FORM 8-K | 0001437749-26-015013 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-30 | 2026-06-11 | FORM DEF 14A | 0001437749-26-014233 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-04-29 | — | SCHEDULE 13G Filing | 0002100121-26-000832 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-03-27 | — | SCHEDULE 13G/A Filing | 0000102909-26-002442 | View SEC Doc Filr Page |
| 8-K | 2026-03-20 | 2026-03-18 | FORM 8-K | 0001437749-26-009253 | View SEC Doc Filr Page |
| 10-K | 2026-02-27 | 2025-12-31 | FORM 10-K | 0001437749-26-006133 | View SEC Doc Filr Page |
| 8-K | 2026-02-26 | 2026-02-26 | FORM 8-K | 0001437749-26-005733 | View SEC Doc Filr Page |
| 4 | 2026-01-29 | 2026-01-28 | FORM 4 | 0001437749-26-002439 | View SEC Doc Filr Page |
| 8-K | 2026-01-13 | 2026-01-13 | FORM 8-K | 0001437749-26-001194 | View SEC Doc Filr Page |
| 4 | 2026-01-09 | 2026-01-08 | FORM 4 | 0001437749-26-001016 | View SEC Doc Filr Page |
| 4 | 2026-01-09 | 2026-01-08 | FORM 4 | 0001437749-26-001015 | View SEC Doc Filr Page |